{
    "other_tests": [
        {
            "procedure_name": "CASR gene mutation analysis",
            "date": "Not specified",
            "findings": "A heterozygous mutation (R185Q, CGA/H11022CAA) in exon 4 of the CASR gene was identified in the proband.",
            "changes_over_time": "Not specified."
        },
        {
            "procedure_name": "Skeletal survey",
            "date": "Not specified",
            "findings": "Diffuse osteopenia with coarse trabecular changes of the long bones and thinning of the diaphyseal cortices but no fractures.",
            "changes_over_time": "On repeat skeletal survey at 17 months, osteopenia was greatly decreased, and no fractures or architectural abnormalities were detected, although metaphyseal sclerosis of the long bones was also noted."
        },
        {
            "procedure_name": "Pamidronate treatment",
            "date": "At 2 weeks of age",
            "findings": "The infant experienced hypocalcemia following treatment, and further increase in PTH levels occurred.",
            "changes_over_time": "Hypercalcemia recurred within 1 week after the initial dose."
        },
        {
            "procedure_name": "Cinacalcet treatment",
            "date": "At 3 weeks of age",
            "findings": "Single oral dose resulted in decreased PTH levels within 2 hours; blood ionized calcium reached a nadir at 10 hours.",
            "changes_over_time": "After daily administration began, normalization of ionized calcium was achieved, and the suppression of serum PTH and reduction in total serum calcium was maintained long term."
        }
    ]
}